BGESIC-MR TAB(P.BOX)B/L
— Product

BGESIC-MR TAB(P.BOX)B/L

DICLOFENAC 50MG + PARACETAMOL 325MG + CHLORZONE 250MG

BGESIC-MR TAB(P.BOX)B/L is a fixed-dose tablet of diclofenac 50 mg, paracetamol 325 mg and chlorzoxazone 250 mg. It is used for painful musculoskeletal conditions where muscle spasm accompanies inflammation — acute low back pain, neck and shoulder spasm, sprains, strains, and post-traumatic musculoskeletal pain.

01

Benefits

  • Diclofenac inhibits cyclo-oxygenase, reducing prostaglandin production and with it the swelling and inflammatory pain at the site of injury.
  • Chlorzoxazone is a centrally acting muscle relaxant that damps the spinal reflex arcs maintaining muscle spasm.
  • Paracetamol raises the pain threshold centrally, allowing useful analgesia at a lower NSAID burden.
  • Addressing inflammation, spasm and pain in one tablet simplifies the regimen for the patient.
  • Relieving spasm restores range of movement and allows physiotherapy to begin sooner.
02

Side effects

Not everyone gets these. Most are mild and settle as the course finishes.

Common
  • Nausea, indigestion or epigastric discomfort
  • Abdominal pain or diarrhoea
  • Drowsiness, dizziness or light-headedness
  • Headache
Less common
  • Gastric erosion, ulceration or gastrointestinal bleeding
  • Raised liver enzymes on testing
  • Skin rash or itching
  • Orange or reddish-purple discolouration of the urine from chlorzoxazone, which is harmless
Stop and get medical help if any of these occur
  • Black, tarry stools or vomiting of blood
  • Yellowing of the skin or eyes, or persistent right-upper-abdominal pain
  • Chest pain, breathlessness, or weakness or numbness down one side
  • Swelling of the face, lips or tongue, or difficulty breathing
  • Widespread rash with blistering or peeling skin
03

Precautions

  • Diclofenac carries a higher cardiovascular risk than several other NSAIDs. Contraindicated in established ischaemic heart disease, cerebrovascular disease, peripheral arterial disease and moderate to severe heart failure.
  • Contraindicated in active peptic ulcer disease or a history of gastrointestinal bleeding.
  • Contraindicated in severe hepatic or renal impairment, and in NSAID hypersensitivity including aspirin-sensitive asthma.
  • Check the patient's total daily paracetamol intake across all products before adding this one.
  • Avoid alcohol during the course — it raises both gastrointestinal bleeding and liver injury risk, and chlorzoxazone adds to that hepatic risk.
  • May cause drowsiness. Warn the patient before driving or operating machinery.
  • Avoid in the third trimester of pregnancy; use earlier in pregnancy and while breastfeeding only on medical advice.
  • Use the lowest effective dose for the shortest period, and take with or after food.